Arteriosclerosis and Thrombosis, Vol 14, 973-981, Copyright © 1994 by American Heart Association

ARTICLES

Protein tyrosine kinase inhibitors inhibit chemotaxis of vascular smooth muscle cells

K Shimokado, T Yokota, K Umezawa, T Sasaguri and J Ogata
National Cardiovascular Center Research Institute, Osaka, Japan.

The effects of protein tyrosine kinase inhibitors on platelet-derived growth factor (PDGF)-induced chemotaxis in cultured rat aortic smooth muscle cells (SMCs) were investigated to elucidate the role of tyrosine phosphorylation in the chemotaxis of vascular SMCs. Two tyrosine kinase inhibitors, methyl 2,5-dihydroxycinnamate and genistein, inhibited PDGF- induced chemotaxis, the IC50 being 5 and 150 mumol/L, respectively. Methyl cinnamate and genistein partly inhibited the adhesion of SMC to collagen-coated dishes. A chemotaxis assay using double-well culture dishes revealed that both agents also inhibited cell migration after adhesion. H-7, a C kinase inhibitor, did not inhibit either chemotaxis or SMC adhesion at 100 mumol/L. Western blot analysis using anti- phosphotyrosine revealed that the tyrosine kinase inhibitors inhibited the tyrosine phosphorylation of at least two proteins of molecular weight 85 and 95 kD under our experimental conditions. An immunocytochemical study revealed that these inhibitors eliminated tyrosine phosphorylation along the cell margins; these agents also inhibited the reorganization of microtubules and stress fibers, both of which are involved in directional cell locomotion. These findings suggest that tyrosine kinases may play an important role in SMC chemotaxis.

This article has been cited by other articles:

				U. Sharma, N.-E. Rhaleb, S. Pokharel, P. Harding, S. Rasoul, H. Peng, and O. A. Carretero Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1226 - H1232. [Abstract] [Full Text] [PDF]

				F. M Steinberg, N. L Guthrie, A. C Villablanca, K. Kumar, and M. J Murray Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women Am. J. Clinical Nutrition, July 1, 2003; 78(1): 123 - 130. [Abstract] [Full Text] [PDF]

				T. B. Clarkson, M. S. Anthony, and T. M. Morgan Inhibition of Postmenopausal Atherosclerosis Progression: A Comparison of the Effects of Conjugated Equine Estrogens and Soy Phytoestrogens J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 41 - 47. [Abstract] [Full Text]

				J. Yamakoshi, M. K. Piskula, T. Izumi, K. Tobe, M. Saito, S. Kataoka, A. Obata, and M. Kikuchi Isoflavone Aglycone-Rich Extract without Soy Protein Attenuates Atherosclerosis Development in Cholesterol-Fed Rabbits J. Nutr., August 1, 2000; 130(8): 1887 - 1893. [Abstract] [Full Text]

				I. Fishbein, J. Waltenberger, S. Banai, L. Rabinovich, M. Chorny, A. Levitzki, A. Gazit, R. Huber, U. Mayr, S. D. Gertz, et al. Local Delivery of Platelet-Derived Growth Factor Receptor-Specific Tyrphostin Inhibits Neointimal Formation in Rats Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 667 - 676. [Abstract] [Full Text] [PDF]

				M. S. Anthony Soy and Cardiovascular Disease: Cholesterol Lowering and Beyond J. Nutr., March 1, 2000; 130(3): 662 - 662. [Full Text]

				M. Higaki and K. Shimokado Phosphatidylinositol 3-Kinase Is Required for Growth Factor–Induced Amino Acid Uptake by Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2127 - 2132. [Abstract] [Full Text] [PDF]

				S. Banai, Y. Wolf, G. Golomb, A. Pearle, J. Waltenberger, I. Fishbein, A. Schneider, A. Gazit, L. Perez, R. Huber, et al. PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in Swine Circulation, May 19, 1998; 97(19): 1960 - 1969. [Abstract] [Full Text] [PDF]

				U. Hedin, J. Thyberg, J. Roy, A. Dumitrescu, and P. K. Tran Role of Tyrosine Kinases in Extracellular Matrix–Mediated Modulation of Arterial Smooth Muscle Cell Phenotype Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1977 - 1984. [Abstract] [Full Text]

				C. M. Kahler, P. Schratzberger, and C. J. Wiedermann Response of Vascular Smooth Muscle Cells to the Neuropeptide Secretoneurin : A Functional Role for Migration and Proliferation in Vitro Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2029 - 2035. [Abstract] [Full Text]

				M. Higaki, H. Sakaue, W. Ogawa, M. Kasuga, and K. Shimokado Phosphatidylinositol 3-Kinase-independent Signal Transduction Pathway for Platelet-derived Growth Factor-induced Chemotaxis J. Biol. Chem., November 15, 1996; 271(46): 29342 - 29346. [Abstract] [Full Text] [PDF]

				W. Wang, H. J. Chen, K. N. Giedd, A. Schwartz, P. J. Cannon, and L. E. Rabbani T-Cell Lymphokines, Interleukin-4 and Gamma Interferon, Modulate the Induction of Vascular Smooth Muscle Cell Tissue Plasminogen Activator and Migration by Serum and Platelet-Derived Growth Factor Circ. Res., December 1, 1995; 77(6): 1095 - 1106. [Abstract] [Full Text]